Jump to section
To measurably improve the lives of patients through innovation at the heart of advertising technology and healthcare.
Pharma companies have been slower to adopt programmatic advertising due to unique targeting and regulatory challenges. this has hindered their ability to effectively communicate their wellness services and engage the right audiences. DeepIntent was founded to address this gap with technology that enables better communication and more targeted advertising.
The platform is developing a marketplace that integrates offline health data with online identity, creating a privacy-safe environment for media buyers and sellers. This allows pharma companies to connect with target audiences while meeting regulatory standards and making their advertising more efficient.
DeepIntent has a number of awards to its name, including recognition for its HealthFirst Vaccine Audiences solution, which was named one of 2024's most innovative products by PM360. With this and continuing growth, the company is well-positioned to lead in health advertising for years to come.
Steph
Company Specialist at Welcome to the Jungle
Chris Paquette
(Founder & CEO)Previously worked as a Data Scientist at the Memorial Sloan Kettering Cancer Center.
Data
Sales & Account Management